Ethiopia vs Sub-Saharan Africa (excluding high income): Access to anti-retroviral drugs, male
Ethiopia
93.0%
in 2024
Sub-Saharan Africa (excluding high income)
79.8%
in 2024
Ethiopia rank
7th
Sub-Saharan Africa (excluding high income) rank
7th
Access to anti-retroviral drugs, male over time
- Ethiopia
- Sub-Saharan Africa (excluding high income)
How they compare
Ethiopia currently reports 93.0% against 79.8% in Sub-Saharan Africa (excluding high income), a difference of 13.2%.
That makes Ethiopia's figure about 1.2 times Sub-Saharan Africa (excluding high income)'s.
The two have swapped places 1 time across 25 shared years of data; in 2000 it was Sub-Saharan Africa (excluding high income) ahead.
Ethiopia ranks 7th and Sub-Saharan Africa (excluding high income) ranks 7th of 141 countries.
Ethiopia has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Ethiopia | Sub-Saharan Africa (excluding high income) | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 8.6% | 5.7% | 2.9% | Ethiopia |
| 2010s | 61.8% | 42.2% | 19.6% | Ethiopia |
| 2020s | 87.4% | 73.2% | 14.2% | Ethiopia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, male, Ethiopia or Sub-Saharan Africa (excluding high income)?
- Ethiopia, at 93.0% against 79.8% in Sub-Saharan Africa (excluding high income) as of 2024.
- What is the difference in access to anti-retroviral drugs, male between Ethiopia and Sub-Saharan Africa (excluding high income)?
- 13.2%, with Ethiopia ahead.
- How many years of comparable data are there for Ethiopia and Sub-Saharan Africa (excluding high income)?
- 25 years are reported by both, from 2000 to 2024.
- How do Ethiopia and Sub-Saharan Africa (excluding high income) rank globally for access to anti-retroviral drugs, male?
- Ethiopia ranks 7th and Sub-Saharan Africa (excluding high income) ranks 7th of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, male (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult males living with HIV who are receiving antiretroviral therapy.